CODHy 2027’s Program

Program is subject to updates

Friday, May 21, 2027

08:00–10:00 · Plenary Session 1: Opening Session

Chair: Wang Weiqing (China)

  • 08:30–08:40 Chairs’ Opening Speech
  • 08:40–09:00 Opening Ceremony

Opening Report

Chairs: Enrique Caballero (USA); Julio Rosenstock (USA); Stefano Del Prato (Italy)

  • 09:00–09:20 China’s Contribution to Global Diabetes Research (Ning Guang, China)
  • 09:20–09:40 Is Curing Obesity and Diabetes a Realistic Goal? (Itamar Raz, Israel)
  • 09:40–10:00 The Brain as the Manager of Metabolic Disease (TBD, Int)

10:00–12:00 · Plenary Session 2: Keynote Session

Chairs: Ning Guang (China); Itamar Raz (Israel)

  • 10:00–10:20 Precision Diabetes Care: From Evidence to Personalized Treatment (Enrique Caballero, USA)
  • 10:20–10:40 Cardio-Renal-Metabolic Medicine: A Unified Paradigm (Francesco Cosentino, Sweden)
  • 10:40–11:00 Cardiometabolic Risk Reduction: What the Trials Now Tell Us (Antonio Ceriello, Italy)
  • 11:00–11:20 Keynote Speaker (TBD, Int)
  • 11:20–11:40 Keynote Lecture (TBD, China)

11:40–12:00 Hall Turnover and Lunch Box Pickup

12:00–14:00 Lunch Symposium A (Hall A) · Lunch Symposium B (Hall B) · Lunch Symposium C (Hall C)

14:00–15:30

Hall A

Session 1 | AI & Digital Medicine

Chairs: TBD (Int); Kun-Ho Yoon (South Korea)

  • 14:00–14:15 AI and Digital Twins in Diabetes Care (TBD, Int)
  • 14:15–14:30 CGM and Continuous Biological Monitoring (Tadej Battelino, Slovenia)
  • 14:30–14:45 Digital Health Implementation in Asia (Kun-Ho Yoon, South Korea)
  • 14:45–15:00 The Chinese AI Ecosystem in Diabetes (TBD, China)
  • 15:00–15:15 Real-World Evidence from Digital Platforms (TBD, China)
  • 15:15–15:30 Q&A and Panel Discussion
Hall B

Session 2 | Incretin Biology & Obesity Science

Chairs: TBD; TBD

  • 14:00–14:15 Triple Agonists and the Next Generation of Incretins (TBD, Int)
  • 14:15–14:30 Obesity Pharmacotherapy: Real-World Evidence & Guidelines (TBD, Int)
  • 14:30–14:45 Obesity & Metabolic Surgery: Where Do We Stand? (Francesco Rubino, UK)
  • 14:45–15:00 Incretin-Based Therapy in Chinese Patients (TBD, China)
  • 15:00–15:15 Weight Management in China: Clinical Experience (TBD, China)
  • 15:15–15:30 Q&A and Panel Discussion
Hall C

Session 3 | Cardio-Renal-Metabolic Medicine

Chairs: Francesco Cosentino (Sweden); TBD (Int)

  • 14:00–14:15 The Future of Complication Prevention: Heart Failure (Francesco Cosentino, Sweden)
  • 14:15–14:30 Kidney Protection in Diabetes (Per-Henrik Groop, Finland)
  • 14:30–14:45 Precision Prevention of Cardiometabolic Disease (TBD, China)
  • 14:45–15:00 CKM Management in Chinese Patients (TBD, China)
  • 15:00–15:15 Cardio-Renal Outcomes: China Data (TBD, China)
  • 15:15–15:30 Q&A and Panel Discussion

15:30–17:00

Hall A

Session 4 | Obesity, Brain & Behavior

Chairs: TBD (Int); TBD (Int)

  • 15:30–15:45 Obesity as a Chronic Metabolic Disease (TBD, Int)
  • 15:45–16:00 Muscle Biology in Metabolic Health (TBD, Int)
  • 16:00–16:15 Self-Control and Obesity: Neurological and Involuntary? (TBD, China)
  • 16:15–16:30 Stress, Cortisol, Visceral Fat & Mental Health (TBD, China)
  • 16:30–16:45 Sleep, Obesity and Metabolic Risk (TBD)
  • 16:45–17:00 Q&A and Panel Discussion
Hall B

Session 5 | Liver, Gut & MASLD

Chairs: TBD (Int); Stefano Del Prato (Italy)

  • 15:30–15:45 MASLD: From Mechanisms to Therapy (Stefano Del Prato, Italy)
  • 15:45–16:00 MASLD in Asian Patients (TBD, Int)
  • 16:00–16:15 The Gut Microbiome in Obesity and Diabetes (TBD, China)
  • 16:15–16:30 MASLD in Chinese Patients: Clinical Practice (TBD, China)
  • 16:30–16:45 Precision Nutrition: Evidence-Based or Marketing? (TBD, Int)
  • 16:45–17:00 Q&A and Panel Discussion
Hall C

Session 6 | Disease Modification: Remission & Cell Therapy

Chairs: TBD (Int); TBD (Int)

  • 15:30–15:45 Beta-Cell Preservation and Disease Modification (TBD, Int)
  • 15:45–16:00 Immunometabolism & Immune Modulation in T1D (TBD, Int)
  • 16:00–16:15 T2D Remission in China: Real Healing or Temporary Repose? (TBD, China)
  • 16:15–16:30 Cell Therapy: China Progress (TBD, China)
  • 16:30–16:45 Beta-Cell Biology in Asian Young-Onset Diabetes (Kun-Ho Yoon, South Korea)
  • 16:45–17:00 Q&A and Panel Discussion

17:00–18:00 CODHy Master Class Series — Interactive Learning with World Leaders. Divided into several private rooms, each dedicated to a different topic.

Saturday, May 22, 2027

08:30–10:10

Hall A

Session 7 | The Future of Diabetes

Chairs: Itamar Raz (Israel); Julio Rosenstock (USA)

  • 08:30–08:50 The Future of Diabetes Care (Itamar Raz, Israel)
  • 08:50–09:10 Clinical Diabetes: Lessons from Recent Trials (Julio Rosenstock, USA)
  • 09:10–09:30 Effects of GLP-1RA and Tirzepatide Discontinuation (Antonio Ceriello, Italy)
  • 09:30–09:50 China’s Contribution to Global Diabetes Research (TBD, China)
  • 09:50–10:10 Q&A and Panel Discussion
Hall B

Session 8 | Precision Medicine & Longevity

Chairs: Enrique Caballero (USA); Stefano Del Prato (Italy)

  • 08:30–08:50 Precision Medicine: Hype or Reality? (Enrique Caballero, USA)
  • 08:50–09:10 Cardiometabolic Health and Healthy Longevity (TBD, Int)
  • 09:10–09:30 Precision Medicine in Chinese Populations (TBD, China)
  • 09:30–09:50 Genetics and Personalized Medicine in China (TBD, China)
  • 09:50–10:10 Q&A and Panel Discussion
Hall C

Session 9 | Population Health & Real-World Evidence

Chairs: Kamlesh Khunti (UK); TBD (Int)

  • 08:30–08:50 Population Health and Diabetes Prevention (Kamlesh Khunti, UK)
  • 08:50–09:10 Real-World Evidence & Guidelines (TBD, Int)
  • 09:10–09:30 Young-Onset Type 2 Diabetes in China (TBD, China)
  • 09:30–09:50 Real-World Evidence from Chinese Cohorts (TBD, China)
  • 09:50–10:10 Q&A and Panel Discussion

10:10–11:50

Hall A

Session 10 | Cardiometabolic Risk

Chairs: Francesco Cosentino (Sweden); TBD (Int)

  • 10:10–10:30 Cardiometabolic Risk: New Frontiers (TBD, Int)
  • 10:30–10:50 Heart Failure Prevention in Diabetes (Francesco Cosentino, Sweden)
  • 10:50–11:10 Hypertension in Metabolic Disease: China Perspective (TBD, China)
  • 11:10–11:30 Cardiometabolic Risk in Chinese Patients (TBD, China)
  • 11:30–11:50 Q&A and Panel Discussion
Hall B

Session 11 | Young Scientist & Rising Star Session

Five young scientists present their research — topics to be confirmed

  • 10:10–10:30 Young Scientist Presentation 1 — to be confirmed
  • 10:30–10:50 Young Scientist Presentation 2 — to be confirmed
  • 10:50–11:10 Young Scientist Presentation 3 — to be confirmed
  • 11:10–11:30 Young Scientist Presentation 4 — to be confirmed
  • 11:30–11:50 Young Scientist Presentation 5 — to be confirmed
Hall C

Session 12 | Diabetic Foot & Limb Preservation

Chairs: TBD (Int); TBD (China)

  • 10:10–10:30 The Future of Diabetic Foot Care (TBD, Int)
  • 10:30–10:50 Limb Preservation and Podiatric Surgery (TBD, Int)
  • 10:50–11:10 The Diabetic Foot in China: Current Situation (TBD, China)
  • 11:10–11:30 Diabetic Foot Management: Chinese Clinical Experience (TBD, China)
  • 11:30–11:50 Q&A and Panel Discussion

11:50–12:00 Lunch Box Pickup

12:00–14:00 Lunch Symposium D (Hall A) · Lunch Symposium E (Hall B) · Lunch Symposium F (Hall C)

14:00–15:30

Hall A

Session 13 | Glycemic Variability & Technology

Chairs: Antonio Ceriello (Italy); TBD (Int)

  • 14:00–14:15 Glycemic Variability: Why It Matters (Antonio Ceriello, Italy)
  • 14:15–14:30 CGM in the Era of AI (TBD, Int)
  • 14:30–14:45 Technology-Enabled Care in Asia (TBD, China)
  • 14:45–15:00 Digital Therapeutics in China (TBD, China)
  • 15:00–15:15 CGM Implementation in Chinese Practice (TBD, China)
  • 15:15–15:30 Q&A and Panel Discussion
Hall B

Session 14 | Muscle Biology & Frontiers in Biology

Chairs: TBD (Int); TBD (Int)

  • 14:00–14:15 Muscle as a Metabolic Organ (TBD, China)
  • 14:15–14:30 Inter-organ Metabolic Communication (TBD, Int)
  • 14:30–14:45 Frontiers in Metabolic Biology (TBD, Int)
  • 14:45–15:00 Muscle Biology Research in China (TBD, China)
  • 15:00–15:15 Single-Cell Insights: China Studies (TBD, China)
  • 15:15–15:30 Q&A and Panel Discussion
Hall C

Session 15 | Asia-Pacific Perspectives

Chairs: TBD (Int); TBD (Int)

  • 14:00–14:15 Diabetes in Asian Populations (TBD, Int)
  • 14:15–14:30 Obesity in Asia (TBD, Int)
  • 14:30–14:45 Diabetes Care in Southeast Asia (TBD, Int)
  • 14:45–15:00 Diabetes in Chinese Populations (TBD, China)
  • 15:00–15:15 China’s Contribution to Asian Diabetes Research (TBD, China)
  • 15:15–15:30 Q&A and Panel Discussion

15:30–17:00

Hall A

Session 16 | Clinical Diabetes & Mechanisms

Chairs: Julio Rosenstock (USA); Stefano Del Prato (Italy)

  • 15:30–15:45 Clinical Diabetes: State of the Art (Julio Rosenstock, USA)
  • 15:45–16:00 Mechanisms & Translational Science (Stefano Del Prato, Italy)
  • 16:00–16:15 Reducing Therapeutic Inertia (TBD, China)
  • 16:15–16:30 Clinical Diabetes Management in China (TBD, China)
  • 16:30–16:45 Translational Research from China (TBD, China)
  • 16:45–17:00 Q&A and Panel Discussion
Hall B

Session 17 | Immunometabolism & Guideline Implementation

Chairs: TBD (Int); Kamlesh Khunti (UK)

  • 15:30–15:45 Immunometabolism in Diabetes (TBD, Int)
  • 15:45–16:00 Guideline Implementation Across Populations (Kamlesh Khunti, UK)
  • 16:00–16:15 Bridging Guidelines and Practice (TBD, China)
  • 16:15–16:30 Chinese Diabetes Guidelines: Implementation (TBD, China)
  • 16:30–16:45 Immunometabolism Research in China (TBD, China)
  • 16:45–17:00 Q&A and Panel Discussion
Hall C

MMC Session

  • 15:30–18:00 Reserved for MMC — no program scheduled. Room available until 18:00.